Home Gero

Gero

In operation
Series A
AI Drug Discovery Platform
Basic
Enterprise Profile

Basic Information

Gero is an AI-driven platform dedicated to drug discovery and drug repurposing for complex diseases and aging. It also analyzes clinical and genetic data to identify treatments for some of the most complex diseases, such as those related to chronic aging and mental disorders. The company's experts utilize large medical and genetic information datasets obtained from biobanks, covering hundreds of thousands of individuals, and have created a proprietary database of blood samples collected during the last 15 years of patients' lives.Gero conducts high-quality research supported by collaborations with researchers from globally leading institutions such as Harvard Medical School, MIT, the University of Edinburgh, the National University of Singapore, and the Roswell Park Comprehensive Cancer Center to develop new therapies.
Gero PTE LTD
Singapore
15~50 people
January 01, 2012
info@gero.ai

Enterprise Profile

Industrial Sector
New Drug Development Industry Database CRO
Technology
Artificial Intelligence
Concept
Mental Disorders Chronic Disease
Application Scenarios
Smart Healthcare Big Data